Design and Rationale of a Phase 2 Study of NeurOtoxin (Botulinum Toxin Type A) for the PreVention of Post-Operative Atrial Fibrillation – The NOVA Study - Concepedia

Concepedia

Publication | Closed Access

Design and Rationale of a Phase 2 Study of NeurOtoxin (Botulinum Toxin Type A) for the PreVention of Post-Operative Atrial Fibrillation – The NOVA Study

21

Citations

21

References

2021

Year

Jonathan P. Piccini, Anders Ahlsson, Paul Dorian, Marc A. Gillinov, Peter R. Kowey, Michael J. Mack, Carmelo A. Milano, Louis P. Perrault, Jonathan S. Steinberg, Nathan H. Waldron,

American Heart Journal

Nova StudyPost-operative Atrial FibrillationNeurologyElectrophysiologyPhase 2MedicineCardiology

References

	Year	Citations

Page 1